1
|
Huang J, Fu Y, Wang A, Shi K, Peng Y, Yi Y, Yu R, Gao J, Feng J, Jiang G, Song Q, Jiang J, Chen H, Gao X. Brain Delivery of Protein Therapeutics by Cell Matrix-Inspired Biomimetic Nanocarrier. ADVANCED MATERIALS (DEERFIELD BEACH, FLA.) 2024:e2405323. [PMID: 38718295 DOI: 10.1002/adma.202405323] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/14/2024] [Indexed: 05/24/2024]
Abstract
Protein therapeutics are anticipated to offer significant treatment options for central nervous system (CNS) diseases. However, the majority of proteins are unable to traverse the blood-brain barrier (BBB) and reach their CNS target sites. Inspired by the natural environment of active proteins, the cell matrix components hyaluronic acid (HA) and protamine (PRTM) are used to self-assemble with proteins to form a protein-loaded biomimetic core and then incorporated into ApoE3-reconstituted high-density lipoprotein (rHDL) to form a protein-loaded biomimetic nanocarrier (Protein-HA-PRTM-rHDL). This cell matrix-inspired biomimetic nanocarrier facilitates the penetration of protein therapeutics across the BBB and enables their access to intracellular target sites. Specifically, CAT-HA-PRTM-rHDL facilitates rapid intracellular delivery and release of catalase (CAT) via macropinocytosis-activated membrane fusion, resulting in improved spatial learning and memory in traumatic brain injury (TBI) model mice (significantly reduces the latency of TBI mice and doubles the number of crossing platforms), and enhances motor function and prolongs survival in amyotrophic lateral sclerosis (ALS) model mice (extended the median survival of ALS mice by more than 10 days). Collectively, this cell matrix-inspired nanoplatform enables the efficient CNS delivery of protein therapeutics and provides a novel approach for the treatment of CNS diseases.
Collapse
Affiliation(s)
- Jialin Huang
- Department of Pharmacology and Chemical Biology, Shanghai Universities Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
- Brain Injury Center, Renji Hospital, Shanghai Institute of Head Trauma, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China
| | - Yuli Fu
- Department of Pharmacology and Chemical Biology, Shanghai Universities Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
| | - Antian Wang
- Department of Pharmacology and Chemical Biology, Shanghai Universities Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
| | - Kexing Shi
- Department of Pharmacology and Chemical Biology, Shanghai Universities Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
| | - Yidong Peng
- Brain Injury Center, Renji Hospital, Shanghai Institute of Head Trauma, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China
| | - Yao Yi
- Brain Injury Center, Renji Hospital, Shanghai Institute of Head Trauma, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China
| | - Renhe Yu
- Department of Pharmacology and Chemical Biology, Shanghai Universities Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
| | - Jinchao Gao
- Department of Pharmacology and Chemical Biology, Shanghai Universities Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
| | - Junfeng Feng
- Brain Injury Center, Renji Hospital, Shanghai Institute of Head Trauma, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China
| | - Gan Jiang
- Department of Pharmacology and Chemical Biology, Shanghai Universities Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
| | - Qingxiang Song
- Department of Pharmacology and Chemical Biology, Shanghai Universities Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
| | - Jiyao Jiang
- Brain Injury Center, Renji Hospital, Shanghai Institute of Head Trauma, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China
| | - Hongzhuan Chen
- Department of Pharmacology and Chemical Biology, Shanghai Universities Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
- Shuguang Lab for Future Health, Academy of Integrative Medicine, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200021, China
| | - Xiaoling Gao
- Department of Pharmacology and Chemical Biology, Shanghai Universities Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
| |
Collapse
|
2
|
Fukuda R, Tani M, Shibukawa S, Nobeyama T, Nomura T, Kato Y, Murakami T. Effects of lipoprotein nanoparticles' composition and size on their internalization in plant and mammalian cells. Genes Cells 2023; 28:881-892. [PMID: 37850683 DOI: 10.1111/gtc.13075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2023] [Revised: 10/02/2023] [Accepted: 10/05/2023] [Indexed: 10/19/2023]
Abstract
The internalization of engineered high-density lipoprotein nanoparticles (engineered lipoproteins [eLPs]) with different lipid and protein compositions, zeta potentials, and/or sizes were analyzed in representative plant and mammalian cells. The impact of the addition of a cell-penetrating peptide to eLPs on the internalization was very small in Bright Yellow (BY)-2 protoplasts compared with HeLa cells. When eLPs were prepared with one of the abundant lipids in BY-2 cells, digalactosyldiacylglycerol (DGDG) (eLP4), its internalization was dramatically increased only in HeLa cells. Such an increase in HeLa cells was also obtained for liposomes containing DGDG in a DGDG content-dependent manner. Increasing the size and zeta potential of eLPs improved their internalization in both HeLa cells and in BY-2 protoplasts but to quite varying degrees. Although eLPs tended to stay at the plasma membrane (PM) in BY-2 protoplasts with much less internalization, the PM-bound eLPs somehow promoted the internalization of coexisting nanobeads in cell culture media. These results provide fundamental insight into the future design of lipid nanoparticles for drug delivery in mammalian and plant cells.
Collapse
Affiliation(s)
- Ryosuke Fukuda
- Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, Toyama, Japan
- Biotechnology Research Center, Toyama Prefectural University, Toyama, Japan
| | - Misaki Tani
- Biotechnology Research Center, Toyama Prefectural University, Toyama, Japan
- Department of Biotechnology, Graduate School of Engineering, Toyama Prefectural University, Toyama, Japan
| | - Shiori Shibukawa
- Biotechnology Research Center, Toyama Prefectural University, Toyama, Japan
- Department of Biotechnology, Graduate School of Engineering, Toyama Prefectural University, Toyama, Japan
| | - Tomohiro Nobeyama
- Biotechnology Research Center, Toyama Prefectural University, Toyama, Japan
- Department of Biotechnology, Graduate School of Engineering, Toyama Prefectural University, Toyama, Japan
| | - Taiji Nomura
- Biotechnology Research Center, Toyama Prefectural University, Toyama, Japan
- Department of Biotechnology, Graduate School of Engineering, Toyama Prefectural University, Toyama, Japan
| | - Yasuo Kato
- Biotechnology Research Center, Toyama Prefectural University, Toyama, Japan
- Department of Biotechnology, Graduate School of Engineering, Toyama Prefectural University, Toyama, Japan
| | - Tatsuya Murakami
- Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, Toyama, Japan
- Biotechnology Research Center, Toyama Prefectural University, Toyama, Japan
- Department of Biotechnology, Graduate School of Engineering, Toyama Prefectural University, Toyama, Japan
- Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto University, Kyoto, Japan
| |
Collapse
|
3
|
Stępień P, Świątek S, Robles MYY, Markiewicz-Mizera J, Balakrishnan D, Inaba-Inoue S, De Vries AH, Beis K, Marrink SJ, Heddle JG. CRAFTing Delivery of Membrane Proteins into Protocells using Nanodiscs. ACS APPLIED MATERIALS & INTERFACES 2023; 15. [PMID: 38015973 PMCID: PMC10726305 DOI: 10.1021/acsami.3c11894] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/11/2023] [Revised: 11/07/2023] [Accepted: 11/07/2023] [Indexed: 11/30/2023]
Abstract
For the successful generative engineering of functional artificial cells, a convenient and controllable means of delivering membrane proteins into membrane lipid bilayers is necessary. Here we report a delivery system that achieves this by employing membrane protein-carrying nanodiscs and the calcium-dependent fusion of phosphatidylserine lipid membranes. We show that lipid nanodiscs can fuse a transported lipid bilayer with the lipid bilayers of small unilamellar vesicles (SUVs) or giant unilamellar vesicles (GUVs) while avoiding recipient vesicles aggregation. This is triggered by a simple, transient increase in calcium concentration, which results in efficient and rapid fusion in a one-pot reaction. Furthermore, nanodiscs can be loaded with membrane proteins that can be delivered into target SUV or GUV membranes in a detergent-independent fashion while retaining their functionality. Nanodiscs have a proven ability to carry a wide range of membrane proteins, control their oligomeric state, and are highly adaptable. Given this, our approach may be the basis for the development of useful tools that will allow bespoke delivery of membrane proteins to protocells, equipping them with the cell-like ability to exchange material across outer/subcellular membranes.
Collapse
Affiliation(s)
- Piotr Stępień
- Malopolska
Centre of Biotechnology, Jagiellonian University, Krakow 30-387, Poland
| | - Sylwia Świątek
- Malopolska
Centre of Biotechnology, Jagiellonian University, Krakow 30-387, Poland
| | | | | | - Dhanasekaran Balakrishnan
- Malopolska
Centre of Biotechnology, Jagiellonian University, Krakow 30-387, Poland
- Postgraduate
School of Molecular Medicine, Żwirki i Wigury 61, Warsaw 02-091, Poland
| | - Satomi Inaba-Inoue
- Department
of Life Sciences, Imperial College London, Exhibition Road, South Kensington, London SW7 2AZ, U.K.
- Rutherford
Appleton Laboratory, Research Complex at
Harwell, Didcot, Oxfordshire OX11 0FA, U.K.
| | - Alex H. De Vries
- Groningen
Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen 9747 AG, The Netherlands
| | - Konstantinos Beis
- Department
of Life Sciences, Imperial College London, Exhibition Road, South Kensington, London SW7 2AZ, U.K.
- Rutherford
Appleton Laboratory, Research Complex at
Harwell, Didcot, Oxfordshire OX11 0FA, U.K.
| | - Siewert J. Marrink
- Groningen
Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen 9747 AG, The Netherlands
| | - Jonathan G. Heddle
- Malopolska
Centre of Biotechnology, Jagiellonian University, Krakow 30-387, Poland
| |
Collapse
|
4
|
Kolašinac R, Jaksch S, Dreissen G, Braeutigam A, Merkel R, Csiszár A. Influence of Environmental Conditions on the Fusion of Cationic Liposomes with Living Mammalian Cells. NANOMATERIALS 2019; 9:nano9071025. [PMID: 31319557 PMCID: PMC6669649 DOI: 10.3390/nano9071025] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/06/2019] [Revised: 07/12/2019] [Accepted: 07/12/2019] [Indexed: 12/12/2022]
Abstract
Lipid-based nanoparticles, also called vesicles or liposomes, can be used as carriers for drugs or many types of biological macromolecules, including DNA and proteins. Efficiency and speed of cargo delivery are especially high for carrier vesicles that fuse with the cellular plasma membrane. This occurs for lipid mixture containing equal amounts of the cationic lipid DOTAP and a neutral lipid with an additional few percents of an aromatic substance. The fusion ability of such particles depends on lipid composition with phosphoethanolamine (PE) lipids favoring fusion and phosphatidyl-choline (PC) lipids endocytosis. Here, we examined the effects of temperature, ionic strength, osmolality, and pH on fusion efficiency of cationic liposomes with Chinese hamster ovary (CHO) cells. The phase state of liposomes was analyzed by small angle neutron scattering (SANS). Our results showed that PC containing lipid membranes were organized in the lamellar phase. Here, fusion efficiency depended on buffer conditions and remained vanishingly small at physiological conditions. In contrast, SANS indicated the coexistence of very small (~50 nm) objects with larger, most likely lamellar structures for PE containing lipid particles. The fusion of such particles to cell membranes occurred with very high efficiency at all buffer conditions. We hypothesize that the altered phase state resulted in a highly reduced energetic barrier against fusion.
Collapse
Affiliation(s)
- Rejhana Kolašinac
- Forschungszentrum Jülich GmbH, Institute of Complex Systems: ICS-7 Biomechanics, 52428 Jülich, Germany
| | - Sebastian Jaksch
- Forschungszentrum Jülich GmbH, Jülich Centre for Neutron Science (JCNS) at Heinz Maier-Leibnitz Zentrum (MLZ), 85748 Garching, Germany
| | - Georg Dreissen
- Forschungszentrum Jülich GmbH, Institute of Complex Systems: ICS-7 Biomechanics, 52428 Jülich, Germany
| | - Andrea Braeutigam
- Forschungszentrum Jülich GmbH, Institute of Complex Systems: ICS-2 Theoretical Soft Matter and Biophysics, 52428 Jülich, Germany
| | - Rudolf Merkel
- Forschungszentrum Jülich GmbH, Institute of Complex Systems: ICS-7 Biomechanics, 52428 Jülich, Germany
| | - Agnes Csiszár
- Forschungszentrum Jülich GmbH, Institute of Complex Systems: ICS-7 Biomechanics, 52428 Jülich, Germany.
| |
Collapse
|